Physician profile
Miranda L Thomas
NPI 1427512318
$5,332.18
in general payments reported to CMS, 2019-2025
35 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,510 · 2022: $1,621 · 2023: $1,429 · 2024: $772.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,200 · Education: $1.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,199.60 |
| Education | $1.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $643.85 | 2021-2024 | Erleada |
| Astellas Pharma US INC | $604.70 | 2021-2023 | Myrbetriq |
| Pfizer INC. | $515.98 | 2021-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $493.33 | 2021-2024 | |
| Sumitomo Pharma America, INC. | $420.51 | 2023-2024 | Gemtesa, Orgovyx |
| Endo Pharmaceuticals INC. | $374.86 | 2021-2024 | Edex, Xiaflex, Aveed |
| Urovant Sciences INC | $297.39 | 2021-2022 | |
| Abbvie INC. | $225.97 | 2021-2024 | |
| Myovant Sciences INC. | $182.46 | 2021-2022 | |
| 180 Medical, INC. | $174.35 | 2021-2024 | Lofric Origo |
| Myriad Genetic Laboratories, INC. | $162.70 | 2022-2023 | Prolaris |
| Antares Pharma, INC. | $147.60 | 2021-2024 | Xyosted, Tlando, Nocdurna |
| Urogen Pharma, INC. | $136.11 | 2024 | |
| Medtronic, INC. | $133.58 | 2022-2023 | Interstim |
| Dendreon Pharmaceuticals LLC | $93.92 | 2021 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $74.81 | 2021-2024 | |
| Accord Healthcare, INC. | $67.74 | 2022 | |
| Blue Earth Diagnostics | $64.36 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $59.72 | 2021-2023 | Lynparza, Keytruda |
| Axonics, INC. | $55.43 | 2022-2024 | Axonics |
| Progenics Pharmaceuticals, INC. | $54.35 | 2023 | Pylarify |
| Novartis Pharmaceuticals Corporation | $53.61 | 2023 | |
| Tolmar, INC. | $41.91 | 2023-2024 | |
| Allergan, INC. | $35.19 | 2021 | |
| Photocure INC | $33.66 | 2021-2024 | Cysview |
| Kowa Pharmaceuticals America, INC. | $29.47 | 2023 | Seglentis |
| Travere Therapeutics, INC. | $23.28 | 2022-2023 | Thiola |
| Endo USA, INC. | $22.85 | 2024 | Aveed, Xiaflex |
| Foundation Medicine, INC. | $19.26 | 2023 | Foundationone Liquid Cdx |
| Halozyme INC | $16.74 | 2023 | |
| Convatec INC. | $16.70 | 2021 | |
| Procept Biorobotics Corporation | $15.63 | 2023 | Aquabeam Robotic System |
| Boston Scientific Corporation | $15.26 | 2023 | Greenlight Xps |
| Medline Industries Lp | $12.71 | 2023 | |
| Tolmar Pharmaceuticals, INC. | $12.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Miranda Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.